Literature DB >> 8205661

High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men.

A Kitamura1, H Iso, Y Naito, M Iida, M Konishi, A R Folsom, S Sato, M Kiyama, M Nakamura, T Sankai.   

Abstract

BACKGROUND: The objective of this study was to examine the relation of high-density lipoprotein cholesterol (HDL-C) to coronary heart disease in Japanese men whose serum total cholesterol is low by Western standards. METHODS AND
RESULTS: A prospective, observational study based on 7.7 years of follow-up for incidence of coronary heart disease and stroke was conducted. The subjects were 6408 middle-aged male workers aged 40 to 59 years at baseline in urban companies in Osaka, Japan, whose mean serum total cholesterol was 5.10 mmol/L. Mean HDL-C adjusted for age, total cholesterol, systolic blood pressure, alcohol intake, cigarette smoking, and body mass index was 1.27 to 1.28 mmol/L for men who developed coronary heart disease (n = 46) or definite myocardial infarction (n = 21) compared with 1.46 mmol/L for those free of cardiovascular disease (n = 6256; difference, P < .01). There was no significant difference in mean HDL-C between stroke cases (n = 33) and those free of cardiovascular disease. The incidence rates of coronary heart disease and definite myocardial infarction, adjusted for the other risk factors, were three to four times higher in the lowest HDL-C quartile (< 1.24 mmol/L) than the highest quartile (> or = 1.66 mmol/L), and there was a significant dose response for definite myocardial infarction. Serum total cholesterol was positively and significantly associated with coronary heart disease incidence. Furthermore, the inverse association for HDL-C was apparent among men with total cholesterol < 5.69 mmol/L (mean total cholesterol, 4.76 mmol/L) and men with total cholesterol > or = 5.69 mmol/L (mean total cholesterol, 6.26 mmol/L).
CONCLUSIONS: Coronary heart disease incidence is inversely related to HDL-C in urban Japanese middle-aged men, whose mean total cholesterol (5.10 mmol/L) is relatively low.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205661     DOI: 10.1161/01.cir.89.6.2533

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  37 in total

Review 1.  Impact of lifestyle changes on plasma lipid levels and ischemic disease.

Authors:  T Teramoto
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

Review 2.  Experimental models for the investigation of high-density lipoprotein-mediated cholesterol efflux.

Authors:  Carlos G Santos-Gallego; Chiara Giannarelli; Juan José Badimón
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

Review 3.  Resistive exercise training in cardiac rehabilitation. An update.

Authors:  D E Verrill; P M Ribisl
Journal:  Sports Med       Date:  1996-05       Impact factor: 11.136

4.  Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study.

Authors:  Akira Sekikawa; Yoshihiro Miyamoto; Katsuyuki Miura; Kunihiro Nishimura; Bradley J Willcox; Kamal H Masaki; Beatriz Rodriguez; Russell P Tracy; Tomonori Okamura; Lewis H Kuller
Journal:  Int J Epidemiol       Date:  2015-07-16       Impact factor: 7.196

5.  The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population.

Authors:  Aya Hirata; Tomonori Okamura; Daisuke Sugiyama; Kazuyo Kuwabara; Aya Kadota; Akira Fujiyoshi; Katsuyuki Miura; Nagako Okuda; Takayoshi Ohkubo; Akira Okayama; Hirotsugu Ueshima
Journal:  J Atheroscler Thromb       Date:  2016-02-26       Impact factor: 4.928

6.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

7.  A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.

Authors:  Takumi Hirata; Daisuke Sugiyama; Shin-Ya Nagasawa; Yoshitaka Murakami; Shigeyuki Saitoh; Akira Okayama; Hiroyasu Iso; Fujiko Irie; Toshimi Sairenchi; Yoshihiro Miyamoto; Michiko Yamada; Shizukiyo Ishikawa; Katsuyuki Miura; Hirotsugu Ueshima; Tomonori Okamura
Journal:  Eur J Epidemiol       Date:  2016-10-05       Impact factor: 8.082

8.  BMI modifies the association between serum HDL cholesterol and stroke in a hypertensive population without atrial fibrillation.

Authors:  Y Yu; L Hu; X Huang; W Zhou; H Bao; X Cheng
Journal:  J Endocrinol Invest       Date:  2020-05-13       Impact factor: 4.256

Review 9.  Diabetic dyslipidemia: evaluation and mechanism.

Authors:  Hidekatsu Yanai; Yuji Hirowatari; Hiroshi Yoshida
Journal:  Glob Health Med       Date:  2019-10-31

10.  HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method.

Authors:  Masakazu Nakamura; Shinji Yokoyama; Yuzo Kayamori; Hiroyasu Iso; Akihiko Kitamura; Tomonori Okamura; Masahiko Kiyama; Hiroyuki Noda; Kunihiro Nishimura; Michikazu Nakai; Isao Koyama; Mahnaz Dasti; Hubert W Vesper; Tamio Teramoto; Yoshihiro Miyamoto
Journal:  Clin Chim Acta       Date:  2014-10-31       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.